Lava Therapeutics is headquartered in Utrecht, Netherlands.
Lava Therapeutics disclosed revenue of 12M USD for 2024 and 7M USD for 2023.
Lava Therapeutics is a life science company.
Lava Therapeutics was founded in 2016.
Yalelaan 62,
Utrecht,
3584 CM
Netherlands,
+31 85 016 3100
www.lavatherapeutics.com
Lava Therapeutics focused on applying its expertise in gamma-delta T cell engagers (TCEs) to transform cancer therapy. The company's platform generates therapeutics that specifically activate a unique and relatively abundant effector gamma-delta T cell subset called Vγ9Vδ2 (Vgamma9-Vdelta2) T cells that have the ability to trigger the activity of immune cells of both the innate and adaptive immune system. Its gamma-delta bsTCEs have demonstrated superior efficacy and safety profiles compared to other bsTCE approaches in preclinical studies and show preferential activity against tumor cells thereby potentially limiting toxicity in healthy tissue. Lava Therapeutics was founded in 2016 and is based in Utrecht, Netherlands.
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
